Furthermore, it has been shown that 100% of metastatic, castration-resistant prostate cancers (CRPC) express EGFR, suggesting that EGFR signaling plays an important role in the progression of prostate cancer [49, 50]. Here, EGFR is linked to prostate carcinoma.